216 related articles for article (PubMed ID: 11857378)
1. Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer.
Toi M; Bando H; Ogawa T; Muta M; Hornig C; Weich HA
Int J Cancer; 2002 Mar; 98(1):14-8. PubMed ID: 11857378
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
[TBL] [Abstract][Full Text] [Related]
3. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis.
Yamaguchi T; Bando H; Mori T; Takahashi K; Matsumoto H; Yasutome M; Weich H; Toi M
Cancer Sci; 2007 Mar; 98(3):405-10. PubMed ID: 17214745
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-4 and granulocyte-macrophage colony-stimulating factor mediates the upregulation of soluble vascular endothelial growth factor receptor-1 in RAW264.7 cells-a process in which p38 mitogen-activated protein kinase signaling has an important role.
Xia L; Dong Z; Zhang Y; Zhang X; Song X; Sun M; Hu Y; Liu S; Wang K; Qu X; Wei F
J Microbiol Immunol Infect; 2016 Jun; 49(3):344-51. PubMed ID: 25132397
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer.
Volm M; Koomägi R; Mattern J
Int J Cancer; 1997 Feb; 74(1):64-8. PubMed ID: 9036871
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome.
Verstovsek S; Estey E; Manshouri T; Giles FJ; Cortes J; Beran M; Rogers A; Keating M; Kantarjian H; Albitar M
Br J Haematol; 2002 Jul; 118(1):151-6. PubMed ID: 12100142
[TBL] [Abstract][Full Text] [Related]
8. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
9. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression.
Toi M; Inada K; Suzuki H; Tominaga T
Breast Cancer Res Treat; 1995; 36(2):193-204. PubMed ID: 8534867
[TBL] [Abstract][Full Text] [Related]
10. Oedema extension in cerebral metastasis and correlation with the expression of nitric oxide synthase isozymes (NOS I-III).
Ludwig HC; Ahkavan-Shigari R; Rausch S; Schallock K; Quentin C; Ziegler D; Bockermann V; Markakis E
Anticancer Res; 2000; 20(1A):305-10. PubMed ID: 10769672
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus.
Winther H; Ahmed A; Dantzer V
Placenta; 1999 Jan; 20(1):35-43. PubMed ID: 9950143
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of vascular endothelial growth factor in breast cancer.
Gasparini G
Oncologist; 2000; 5 Suppl 1():37-44. PubMed ID: 10804090
[TBL] [Abstract][Full Text] [Related]
14. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma.
Tanigawa N; Amaya H; Matsumura M; Shimomatsuya T
J Clin Oncol; 1997 Feb; 15(2):826-32. PubMed ID: 9053510
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C
Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896
[TBL] [Abstract][Full Text] [Related]
16. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic value of vascular endothelial growth factor in breast cancer].
Jing J; Zhao Y; Li H; Zhang S; Shi Z
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):566-8. PubMed ID: 12528550
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival.
Obermair A; Kucera E; Mayerhofer K; Speiser P; Seifert M; Czerwenka K; Kaider A; Leodolter S; Kainz C; Zeillinger R
Int J Cancer; 1997 Aug; 74(4):455-8. PubMed ID: 9291439
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
[TBL] [Abstract][Full Text] [Related]
20. A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.
Wu FT; Stefanini MO; Mac Gabhann F; Popel AS
PLoS One; 2009; 4(4):e5108. PubMed ID: 19352513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
